 In January earlier this year, I wrote an article on Bausch Health Companies BHC , Financial, in which I speculated that the upcoming spin-off of the Bausch Lomb eye care business and its aesthetic business named Solta would unlock tremendous value. After publishing that article, I invested in the stock. 